Supplementary Figures 1-4 from A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
Open Access
- 30 March 2023
- other
- Published by American Association for Cancer Research (AACR)
Abstract
Supplementary Figures 1-4 from A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma PatientsKeywords
This publication has 0 references indexed in Scilit: